JP2018525419A - リドカインを配合した非水性貼付剤 - Google Patents

リドカインを配合した非水性貼付剤 Download PDF

Info

Publication number
JP2018525419A
JP2018525419A JP2018510538A JP2018510538A JP2018525419A JP 2018525419 A JP2018525419 A JP 2018525419A JP 2018510538 A JP2018510538 A JP 2018510538A JP 2018510538 A JP2018510538 A JP 2018510538A JP 2018525419 A JP2018525419 A JP 2018525419A
Authority
JP
Japan
Prior art keywords
lidocaine
patch
tape
patient
pharmacokinetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018510538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018525419A5 (enExample
Inventor
森　達也
達也 森
直之 財田
直之 財田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oishi Koseido Co Ltd
Itochu Chemical Frontier Corp
Original Assignee
Oishi Koseido Co Ltd
Itochu Chemical Frontier Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oishi Koseido Co Ltd, Itochu Chemical Frontier Corp filed Critical Oishi Koseido Co Ltd
Publication of JP2018525419A publication Critical patent/JP2018525419A/ja
Publication of JP2018525419A5 publication Critical patent/JP2018525419A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018510538A 2015-08-24 2016-08-24 リドカインを配合した非水性貼付剤 Pending JP2018525419A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562208985P 2015-08-24 2015-08-24
US62/208,985 2015-08-24
PCT/JP2016/075376 WO2017034041A1 (en) 2015-08-24 2016-08-24 Non-aqueous patch comprising lidocaine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020067603A Division JP2020114862A (ja) 2015-08-24 2020-04-03 リドカインを配合した非水性貼付剤

Publications (2)

Publication Number Publication Date
JP2018525419A true JP2018525419A (ja) 2018-09-06
JP2018525419A5 JP2018525419A5 (enExample) 2019-04-04

Family

ID=57121473

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018510538A Pending JP2018525419A (ja) 2015-08-24 2016-08-24 リドカインを配合した非水性貼付剤
JP2020067603A Pending JP2020114862A (ja) 2015-08-24 2020-04-03 リドカインを配合した非水性貼付剤
JP2022110954A Pending JP2022133471A (ja) 2015-08-24 2022-07-11 リドカインを配合した非水性貼付剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020067603A Pending JP2020114862A (ja) 2015-08-24 2020-04-03 リドカインを配合した非水性貼付剤
JP2022110954A Pending JP2022133471A (ja) 2015-08-24 2022-07-11 リドカインを配合した非水性貼付剤

Country Status (17)

Country Link
US (2) US20180177742A1 (enExample)
EP (1) EP3331515A1 (enExample)
JP (3) JP2018525419A (enExample)
KR (1) KR20180042378A (enExample)
CN (2) CN113893231A (enExample)
AU (2) AU2016312038A1 (enExample)
BR (1) BR112018003617A2 (enExample)
CA (1) CA2996485A1 (enExample)
HK (1) HK1255255A1 (enExample)
IL (1) IL257529A (enExample)
MX (1) MX2018002191A (enExample)
PE (2) PE20181163A1 (enExample)
PH (1) PH12018500375A1 (enExample)
RU (1) RU2018110325A (enExample)
SG (1) SG10202007647YA (enExample)
WO (1) WO2017034041A1 (enExample)
ZA (1) ZA201801305B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186287B2 (en) 2022-05-02 2025-01-07 Hisamitsu Pharmaceutical Co., Inc. Lidocaine-containing patch

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
WO2012153396A1 (ja) 2011-05-10 2012-11-15 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
MX367430B (es) 2011-09-27 2019-07-11 Itochu Chemical Frontier Corp Parche no acuoso.
WO2020250144A2 (en) * 2019-06-10 2020-12-17 Azista Industries Pvt Ltd Lidocaine matrix adhesive patch and it's process

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010016219A1 (ja) * 2008-08-05 2010-02-11 株式会社メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
JP2010202663A (ja) * 2001-10-25 2010-09-16 Endo Pharmaceuticals Inc 非神経障害性疼痛を処置するための方法
JP2011521975A (ja) * 2008-05-30 2011-07-28 オリエント ファーマ シーオー．，エルティーディー． 医薬化合物の経皮送達のための組成物と方法
WO2012153396A1 (ja) * 2011-05-10 2012-11-15 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
WO2013046335A1 (ja) * 2011-09-27 2013-04-04 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101002759A (zh) * 2007-01-12 2007-07-25 陶燃 盐酸利多卡因和薄荷醇的透皮贴片制剂
CN101530401A (zh) * 2008-03-12 2009-09-16 中山市中健药物研究所有限公司 一种用于治疗急慢性炎性疼痛的复方透皮贴片

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010202663A (ja) * 2001-10-25 2010-09-16 Endo Pharmaceuticals Inc 非神経障害性疼痛を処置するための方法
JP2011521975A (ja) * 2008-05-30 2011-07-28 オリエント ファーマ シーオー．，エルティーディー． 医薬化合物の経皮送達のための組成物と方法
WO2010016219A1 (ja) * 2008-08-05 2010-02-11 株式会社メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
WO2012153396A1 (ja) * 2011-05-10 2012-11-15 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
WO2013046335A1 (ja) * 2011-09-27 2013-04-04 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12186287B2 (en) 2022-05-02 2025-01-07 Hisamitsu Pharmaceutical Co., Inc. Lidocaine-containing patch

Also Published As

Publication number Publication date
CA2996485A1 (en) 2017-03-02
US20180177742A1 (en) 2018-06-28
IL257529A (en) 2018-04-30
CN113893231A (zh) 2022-01-07
PE20181163A1 (es) 2018-07-19
PE20240681A1 (es) 2024-04-10
BR112018003617A2 (pt) 2018-12-11
HK1255255A1 (zh) 2019-08-09
JP2020114862A (ja) 2020-07-30
SG10202007647YA (en) 2020-09-29
ZA201801305B (en) 2019-07-31
CN108024979A (zh) 2018-05-11
EP3331515A1 (en) 2018-06-13
AU2016312038A1 (en) 2018-03-15
KR20180042378A (ko) 2018-04-25
JP2022133471A (ja) 2022-09-13
WO2017034041A1 (en) 2017-03-02
RU2018110325A (ru) 2019-09-26
AU2022202121A1 (en) 2022-04-14
PH12018500375A1 (en) 2018-08-29
MX2018002191A (es) 2018-06-06
US20200230073A1 (en) 2020-07-23
RU2018110325A3 (enExample) 2020-01-20

Similar Documents

Publication Publication Date Title
JP2022133471A (ja) リドカインを配合した非水性貼付剤
JP5403948B2 (ja) メマンチン含有経皮吸収製剤
US10617655B2 (en) Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same
WO2003032960A1 (en) Percutaneous absorption preparations
JP2022087276A (ja) メマンチン経皮送達システム
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
KR102704773B1 (ko) 도네페질을 함유하는 경피흡수제제
WO2013140799A1 (ja) 経皮吸収型製剤
US20100158990A1 (en) Transdermal method and patch for corticosteroid administration
JP2004067539A (ja) 経皮投与用貼付剤
US20070082037A1 (en) Transdermal preparations and method for relieving side effects in pergolide therapy
US20180221299A1 (en) Transdermal delivery system
JPH0640917A (ja) トルペリゾン又はエペリゾン含有ハップ剤
WO2024112391A1 (en) Compositions for local delivery of drug actives
TW202440102A (zh) 含多奈哌齊之經皮吸收製劑
CN117064866A (zh) 一种布瑞哌唑长效透皮贴剂及其制备方法
WO2013061588A1 (ja) 経皮吸収型製剤
Phelan et al. Effect of Hepatic Impairment on the Pharmacokinetics of Dalcetrapib
HK1117029A (en) Transdermal method and patch for nausea

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190221

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20191210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200128

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200609